CSIMarket
 
Scisparc Ltd   (SPRC)
Other Ticker:  
 
 
Price: $2.4300 $0.05 2.101%
Day's High: $2.46 Week Perf: -16.49 %
Day's Low: $ 2.26 30 Day Perf: -31.36 %
Volume (M): 279 52 Wk High: $ 14.22
Volume (M$): $ 677 52 Wk Avg: $2.48
Open: $2.39 52 Wk Low: $0.14



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 0
 Employees -
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) 3
 Cash Flow (TTM) (Millions $) 7
 Capital Exp. (TTM) (Millions $) 0

Scisparc Ltd
Scisparc Ltd is a technology company that specializes in developing artificial intelligence solutions for the healthcare industry. The company's software and algorithms are designed to analyze complex medical data, provide insights, and assist medical professionals in making accurate diagnoses and treatment decisions. Scisparc's solutions aim to improve patient outcomes, reduce medical errors, and streamline healthcare processes. The company focuses on leveraging cutting-edge technologies like machine learning, natural language processing, and data analytics to deliver innovative and effective healthcare solutions.


   Company Address: 20 Raul Wallenberg St. Tel Aviv 6971916
   Company Phone Number: 3-7175777   Stock Exchange / Ticker: NASDAQ SPRC
   SPRC is expected to report next financial results on April 30, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Clinical Study

Evolving Cancer Treatment and Pain Management: SciSparc's Groundbreaking Discoveries

Published Tue, Mar 12 2024 12:14 PM UTC

In recent years, the pharmaceutical industry has witnessed impressive advancements in the development of innovative therapies to combat various disorders and rare diseases. SciSparc Ltd., a pioneering clinical-stage pharmaceutical company, is at the forefront of this transformative wave. Their relentless dedication to research and development has revolutionized cancer treatm...

Clinical Study

Investigating the Efficacy and Safety of SCI-210 in Children with Autism Spectrum Disorder: A Promising Clinical Trial by SciSparc Ltd.

Published Fri, Mar 8 2024 12:11 PM UTC

Abstract:Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder that affects millions of children worldwide. As the prevalence of ASD continues to rise, there is an urgent need to develop effective treatments to improve the lives of individuals with this condition. In this groundbreaking study, SciSparc Ltd. has initiated a clinical trial to assess the effic...

Clinical Study

1. SciSparc's Game-Changing Pain Management Patent Promises Relief Without Addiction2. Revamping Autism Treatment: SciSparc's Clinical Trial Offers Hope for Children and Families3. SciSparc's Proprietary Therapy SCI-210 Shows Promise in Tackling Autism Spectrum Disorder in Children

Published Wed, Mar 6 2024 9:41 PM UTC

SciSparc Ltd., a leading clinical-stage pharmaceutical company specializing in the development of treatments for central nervous system disorders, has recently received a Canadian patent for its innovative combination of opioids and n-acylethanolamines in pain management. Additionally, the company has announced the initiation of patient recruitment for its clinical trial wit...

Clinical Study

SciSparc's Breakthrough Treatment for Autism Spectrum Disorder Commences Clinical Trial, Offering Hope for Transformative Results

Published Thu, Feb 29 2024 1:35 PM UTC

SciSparc, a leading pharmaceutical company dedicated to developing innovative treatments for neurological disorders, announced today the availability of their SCI-210 treatment at a clinical site for a groundbreaking clinical trial focused on Autism Spectrum Disorder (ASD) in pediatric patients. This development marks a significant step forward in the search for a safe and e...

Clinical Study

The Dawn of a New Therapeutic Era: SciSparc Spearheads SCI-210 Clinical Trial in Autistic Children.

Published Mon, Jan 29 2024 12:18 PM UTC

The strides being taken in an authentic and innovative experimental approach to addressing the challenges of Autism Spectrum Disorder (ASD) come forth with the announcement by SciSparc Ltd of the initiation of patient recruitment for its monumental clinical trial. Embracing the company's dedication to the development of advanced therapeutic solutions, this trial targets the ...






 

Scisparc Ltd's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com